ATE359767T1 - Pflaster zur äusserlichen anwendung - Google Patents

Pflaster zur äusserlichen anwendung

Info

Publication number
ATE359767T1
ATE359767T1 AT00946484T AT00946484T ATE359767T1 AT E359767 T1 ATE359767 T1 AT E359767T1 AT 00946484 T AT00946484 T AT 00946484T AT 00946484 T AT00946484 T AT 00946484T AT E359767 T1 ATE359767 T1 AT E359767T1
Authority
AT
Austria
Prior art keywords
acid
organic acid
salt
external use
plaster
Prior art date
Application number
AT00946484T
Other languages
English (en)
Inventor
Hideharu Chono
Toshiro Yamaguchi
Hisakazu Kurita
Tetsuro Tateishi
Naruhito Higo
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE359767T1 publication Critical patent/ATE359767T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00946484T 1999-07-27 2000-07-25 Pflaster zur äusserlichen anwendung ATE359767T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21292199 1999-07-27

Publications (1)

Publication Number Publication Date
ATE359767T1 true ATE359767T1 (de) 2007-05-15

Family

ID=16630500

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00946484T ATE359767T1 (de) 1999-07-27 2000-07-25 Pflaster zur äusserlichen anwendung

Country Status (11)

Country Link
EP (1) EP1201232B1 (de)
JP (2) JP4703075B2 (de)
CN (1) CN1222281C (de)
AT (1) ATE359767T1 (de)
AU (1) AU779027B2 (de)
CA (1) CA2378385C (de)
DE (1) DE60034458T2 (de)
DK (1) DK1201232T3 (de)
ES (1) ES2286028T3 (de)
PT (1) PT1201232E (de)
WO (1) WO2001007018A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
WO2002087645A1 (en) 2001-05-01 2002-11-07 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
JP4865958B2 (ja) 2001-05-23 2012-02-01 株式会社トクホン 鎮痛抗炎症局所作用型の貼付剤
JP4354678B2 (ja) * 2002-08-28 2009-10-28 久光製薬株式会社 貼付剤
JP4694967B2 (ja) * 2003-07-31 2011-06-08 久光製薬株式会社 貼付剤
JP4311728B2 (ja) * 2003-12-10 2009-08-12 ニチバン株式会社 経皮吸収型貼付剤
WO2005074894A1 (en) 2004-01-30 2005-08-18 Corium International Rapidly dissolving film for delivery of an active agent
JP4961207B2 (ja) * 2004-04-21 2012-06-27 久光製薬株式会社 粘着基剤中の吸収促進剤の含有率を高めた外用貼付剤
WO2005115355A1 (ja) * 2004-05-28 2005-12-08 Hisamitsu Pharmaceutical Co., Inc. 貼付製剤
WO2005117886A1 (ja) * 2004-06-01 2005-12-15 Hisamitsu Pharmaceutical Co., Inc. 貼付剤
JP5075334B2 (ja) * 2004-11-22 2012-11-21 久光製薬株式会社 薬物含有貼付剤
DE602005010812D1 (de) 2004-11-22 2008-12-18 Hisamitsu Pharmaceutical Co Transdermales Pflaster enthaltend einen schmelzpunktsenkenden Hilfsstoff
US8771726B2 (en) 2006-08-28 2014-07-08 Hisamitsu Pharmaceutical Co., Inc Nail patch
CA2703872C (en) 2007-11-11 2015-11-03 Medrx Co., Ltd. Lidocaine tape preparation
AU2008327436B2 (en) 2007-11-22 2013-09-05 Medrx Co., Ltd. External preparation composition comprising fatty acid-based ionic liquid as active ingredient
EP2258396B1 (de) * 2008-03-03 2017-09-06 Hisamitsu Pharmaceutical Co., Inc. Transdermal absorbierbares präparat
EP2311498A4 (de) * 2008-08-05 2013-07-24 Medrx Co Ltd Externes präparat mit einem fettsäuresalz oder einem benzoesäuresalz aus einer basischen pharmakologischen wirkstoffkomponente sowie verfahren zu seiner herstellung
ITMI20081652A1 (it) * 2008-09-16 2010-03-17 Antica Ritrovati Medicinal I S A R M Srl Soc Composizioni transdermiche per immunoterapia specifica iposensibilizzante
CA2751884C (en) 2009-01-14 2018-09-25 Corium International, Inc. Transdermal administration of tamsulosin
AU2010331264B2 (en) 2009-12-15 2014-05-01 Teikoku Seiyaku Co., Ltd. Transdermal preparation containing basic anti-inflammatory agent
WO2012029097A1 (ja) * 2010-09-03 2012-03-08 株式会社ケイ・エム トランスダーム 経皮吸収製剤
JP6014813B2 (ja) * 2010-09-03 2016-10-26 株式会社 ケイ・エム トランスダーム 経皮吸収製剤および皮膚貼付用粘着シート
EP2700401B1 (de) 2011-04-18 2020-01-15 Hisamitsu Pharmaceutical Co., Inc. Verfahren zur herstellung eines klebepflasters und klebepflaster
US11123305B2 (en) 2012-07-26 2021-09-21 Hisamitsu Pharmaceutical Co., Inc. Patch
US10493156B2 (en) 2012-07-26 2019-12-03 Hisamitsu Pharmaceutical Co., Inc. Patch and method for producing the same
KR102013477B1 (ko) * 2012-07-26 2019-08-22 히사미쓰 세이야꾸 가부시키가이샤 첩부제
AU2013305563B2 (en) * 2012-08-24 2018-09-27 Integurx Therapeutics, Llc Chemical compositions and methods for enhancing transdermal delivery of therapeutic agents
ES2710548T3 (es) * 2012-10-11 2019-04-25 Hisamitsu Pharmaceutical Co Parche transdérmico
JP5270035B1 (ja) 2012-12-06 2013-08-21 久光製薬株式会社 貼付剤及びその製造方法
JP5307931B1 (ja) 2012-12-27 2013-10-02 久光製薬株式会社 貼付剤及びその製造方法
WO2014174564A1 (ja) * 2013-04-22 2014-10-30 祐徳薬品工業株式会社 メマンチン含有経皮吸収型貼付製剤
JP5415645B1 (ja) 2013-06-28 2014-02-12 久光製薬株式会社 貼付剤の製造方法、貼付剤及び包装体
EP4122460A1 (de) 2015-01-09 2023-01-25 Chase Pharmaceuticals Corporation Transdermale oxybutynintherapiesystemkombination
JP6430871B2 (ja) * 2015-03-23 2018-11-28 救急薬品工業株式会社 塩基性薬物塩含有経皮投与テープ剤の製造方法
US9974858B2 (en) 2015-08-29 2018-05-22 Medrx Co., Ltd Percutaneous absorption composition
WO2017037813A1 (ja) * 2015-08-29 2017-03-09 株式会社メドレックス 塩基性薬物とソルビン酸とを含有する経皮吸収組成物
CN106344926A (zh) * 2016-10-31 2017-01-25 魏舒畅 一种后交联凝胶贴膏基质及其制备含药物贴膏剂的方法
JP6748237B2 (ja) 2017-08-01 2020-08-26 久光製薬株式会社 貼付剤
EP3960238A4 (de) * 2019-04-24 2023-01-25 MEDRx Co., Ltd. Lidocainhaltiges pflaster
JP7640498B2 (ja) * 2021-08-04 2025-03-05 久光製薬株式会社 ブロナンセリン含有貼付剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0189861A3 (de) * 1985-01-26 1988-02-17 Showa Denko Kabushiki Kaisha Transdermaler Absorptionsbeschleuniger für ionische wasserlösliche Arzneistoffe
JPH0747535B2 (ja) * 1985-11-26 1995-05-24 日東電工株式会社 消炎鎮痛用貼付剤
US4940456A (en) * 1987-02-10 1990-07-10 Dan Sibalis Electrolytic transdermal delivery of proteins
JP2933944B2 (ja) * 1989-03-29 1999-08-16 日東電工株式会社 医療用貼付剤
JP3526887B2 (ja) * 1993-04-23 2004-05-17 帝國製薬株式会社 消炎鎮痛外用貼付剤
JP3599766B2 (ja) * 1993-12-01 2004-12-08 久光製薬株式会社 貼付製剤
DE69528165T2 (de) * 1994-04-21 2003-05-15 Hisamitsu Pharmaceutical Co., Inc. Transdermal verabreichbare grundlage und daraus hergestelltes transdermal verabreichbares arzneimittel
JP3908795B2 (ja) * 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤
JP4167750B2 (ja) * 1997-04-16 2008-10-22 久光製薬株式会社 経皮吸収用基剤及び該基剤を含有する経皮吸収製剤
WO1999024032A1 (en) * 1997-11-10 1999-05-20 Novo Nordisk A/S Transdermal delivery of 3,4-diarylchromans
US7018647B1 (en) * 1999-12-27 2006-03-28 Teikoku Seiyaku Co., Ltd Patches for external use

Also Published As

Publication number Publication date
AU779027B2 (en) 2005-01-06
JP4703075B2 (ja) 2011-06-15
WO2001007018A1 (fr) 2001-02-01
JP2011079855A (ja) 2011-04-21
DE60034458D1 (de) 2007-05-31
CA2378385C (en) 2009-01-27
JP5180277B2 (ja) 2013-04-10
DK1201232T3 (da) 2007-08-13
EP1201232A1 (de) 2002-05-02
CN1372463A (zh) 2002-10-02
PT1201232E (pt) 2007-07-24
ES2286028T3 (es) 2007-12-01
CA2378385A1 (en) 2001-02-01
DE60034458T2 (de) 2008-01-03
EP1201232B1 (de) 2007-04-18
CN1222281C (zh) 2005-10-12
EP1201232A4 (de) 2004-02-25
AU6024000A (en) 2001-02-13

Similar Documents

Publication Publication Date Title
ATE359767T1 (de) Pflaster zur äusserlichen anwendung
CA2445145A1 (en) Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes
MY151458A (en) Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
CA2248955A1 (en) The use of fumaric acid derivatives
ATE390132T1 (de) Pflaster zur externen anwendung
ATE254928T1 (de) Stabilisierte zusammensetzung mit nootropen wirkstoffen
EP0671162A3 (de) Amphotere Zusammensetzungen und Polymerformen von alpha-Hydroxy-Säuren, und ihre therapeutische Anwendung.
ATE386508T1 (de) Feste orale dosierungsform enthaltend einen resorptionsverstärker
CA2421120A1 (en) Quinolinone derivatives as tyrosine kinase inhibitors
ATE178789T1 (de) Polyester matrix für eine pharmazeutische zusammensetzung mit verzögerter freigabe
RU95112575A (ru) Соль арилпропионовой кислоты, способ ее получения и фармацевтическая композиция
DE60030124D1 (de) Hyaluronsäure-ester zur behandlung von normotrophischen hautnarben
ATE376551T1 (de) Peptidborsäuren und deren verwendung in der herstellung von salzen derselben
DE3679128D1 (de) Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben.
IT1304501B1 (it) Uso di derivati di acidi biliari coniugati con complessi metallicicome "blood pool agents" per l'indagine diagnostica tramite risonanza
EP1269991A3 (de) Topische Zusammensetzung die Ethyllinoleat und/oder Triethylzitrat mit Synergisten
NO20001174L (no) Impregnerte salter, fremgangsmõte for fremstilling av nevnte salter og anvendelse derav
CA2385301A1 (en) Peeling composition
DE3061077D1 (en) Solubilized thymidine composition and method of producing same
DE58909836D1 (de) Zytostatisch wirksame Anthracyclinderivate
WO2001003774A3 (en) Pharmaceutical composition for the treatment of calcification
DE59002790D1 (de) Verfahren zur Herstellung einer Galenischen Zubereitung mit optimaler Bioverfügbarkeit des Wirkstoffs 2-Hydroxy-5-methyllaurophenonoxime (HMLO).
ATE240287T1 (de) Stabilisierung von anhydriden
WO2002007714A3 (en) Use of anellated dihydropyridines for the preparation of pharmaceutical compositions for the treatment of chronic pain
SE9601483L (sv) Beredning av komposition

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties